Azathioprine (Generic for Azasan)

Introducing Azathioprine developed to the Azasan standard—a high‑potency immunosuppressant that inhibits DNA synthesis in proliferating lymphocytes. This formulation is critical for reducing the risk of organ rejection and maintaining graft function. Experience enhanced immunomodulation, improved transplant durability, and superior overall outcomes with this targeted tablet therapy.